Published in Drug Week, July 28th, 2006
Chronogen is a drug discovery company developing therapeutics to treat highly prevalent age-dependent diseases.
The multiyear collaboration between Tripos and Chronogen, which was announced January 2004, combines Tripos' expertise in therapeutic medicinal chemistry and proprietary informatics tools with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.